Oneness Biotech
TWD44.70
0
-TWD2.10-4.49% 05:30 Today
Statistics
Day High
46.5
Day Low
44.5
52W High
76.7
52W Low
40.8
Volume
1,301,810
Avg. Volume
1,332,317
Mkt Cap
21.48B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Dividends
0%Dividend Yield
Jul 2023
TWD0.09
Sep 2015
TWD0.10
Oct 2014
TWD0.19
Oct 2012
TWD0.10
Jul 2010
TWD0.11
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
Nov 5Expected
Q4 2025
Q2 2026
Next
-0.28
0.05
0.38
0.72
Expected EPS
N/A
Actual EPS
N/A
Financials
-809.13%Profit Margin
Unprofitable129.12MRevenue
-1.04BNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Oneness Biotech Co., Ltd., headquartered in Taipei City, Taiwan, functions as a biopharmaceutical enterprise primarily dedicated to the discovery and advancement of novel therapeutic agents, in addition to selling pharmaceutical and health-related merchandise. The company's operations are divided into its New Drug Research and Development segment and its Agricultural Products Cultivation segment. Its advanced therapeutic candidate, ON101, is currently undergoing Phase III clinical trials for the treatment of chronic diabetic foot ulcers. Additionally, OB318, an experimental anti-cancer drug, is progressing through Phase I clinical evaluation. The company's development pipeline further includes FB704A, which has successfully concluded its Phase I clinical trial for addressing rheumatoid arthritis and systemic sclerosis. Furthermore, FB825 is currently in Phase II clinical trials, targeting conditions like atopic dermatitis, various allergic diseases, and asthma. In its earlier stages, FB918, a human monoclonal antibody aimed at allergic asthma, is undergoing pre-clinical development. Beyond its pharmaceutical endeavors, Oneness Biotech also oversees agricultural cultivation and trading activities, encompassing the distribution of farm produce. The company was established and began operations in 2008.
Show More
CEO
Shuling Cheng
Employees
180
Country
Taiwan
ISIN
TW0004743000
Listings
0 Comments
Share your thoughts
FAQs
What is Oneness Biotech stock price today?▼
The current price of 4743.TWO is TWD44.70 TWD — it has decreased by -4.49% in the past 24 hours. Watch Oneness Biotech stock price performance more closely on the chart.
What is Oneness Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Oneness Biotech stocks are traded under the ticker 4743.TWO.
Is Oneness Biotech stock price growing?▼
4743.TWO stock has fallen by -6.19% compared to the previous week, the month change is a -5.2% fall, over the last year Oneness Biotech has showed a -31.86% decrease.
What is Oneness Biotech market cap?▼
Today Oneness Biotech has the market capitalization of 21.48B
When is the next Oneness Biotech earnings date?▼
Oneness Biotech is going to release the next earnings report on November 5, 2026.
What is Oneness Biotech revenue for the last year?▼
Oneness Biotech revenue for the last year amounts to 129.12M TWD.
What is Oneness Biotech net income for the last year?▼
4743.TWO net income for the last year is -1.04B TWD.
Does Oneness Biotech pay dividends?▼
Yes, 4743.TWO dividends are paid annual. The last dividend per share was 0.09 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Oneness Biotech have?▼
As of November 3, 2026, the company has 180 employees.
In which sector is Oneness Biotech located?▼
Oneness Biotech operates in the Health & Wellness sector.
When did Oneness Biotech complete a stock split?▼
The last stock split for Oneness Biotech was on July 26, 2024 with a ratio of 1049.967501:1000.
Where is Oneness Biotech headquartered?▼
Oneness Biotech is headquartered in Taipei, Taiwan.